Gilead Could Acquire Galapagos Within Weeks Post author:Sam Post published:December 17, 2017 Post category:BioPharma Investors are salivating at the possibility of a hot merger-and-acquisition market in 2018. Source: BioSpace You Might Also Like Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017 Aurora Diagnostics Inc. Acquires April 11, 2016 What You Need to Know About Hyalex Orthopaedics January 10, 2018
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017